Vivos Therapeutics Inc (NASDAQ: VVOS) — Perfil da empresa, notícias e dados financeiros
Vivos Therapeutics develops innovative treatments for sleep-disordered breathing, focusing on a non-invasive approach for OSA.
Vivos Therapeutics Inc
Vivos Therapeutics (NASDAQ:VVOS) specializes in developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The company is known for its proprietary Vivos Method, a non-invasive, multifaceted approach to rectify the underlying causes of OSA. By focusing on the dental and orthodontic space, Vivos Therapeutics aims to bring about significant improvements in overall health outcomes for patients dealing with sleep apnea and related conditions. Central to its objectives is the ambition to expand the accessibility of its treatment solutions across diverse patient demographics, striving to alleviate the burdens of sleep-disordered breathing on a global scale.
Resumo
Operações
Produtos e/ou serviços de Vivos Therapeutics Inc
- The Vivos System: A multi-disciplinary treatment protocol aimed at rectifying sleep apnea and related conditions by enhancing and stabilizing the airway.
- DNA/mRNA Appliances: Devices designed to promote dental arch and airway development non-surgically, addressing sleep-disordered breathing.
- Vivos Guide: Specialized for younger patients, this appliance aids in guiding the growth of dental arches to prevent sleep apnea in adulthood.
- SleepImage: A diagnostic tool used for identifying and managing sleep disorders, leveraging a wearable device to analyze sleep patterns.
- Vivos Breathing Wellness Centers: Dedicated facilities providing comprehensive treatment for sleep apnea and related disorders using the Vivos methodology.
equipe executiva do Vivos Therapeutics Inc
- R. Kirk HuntsmanCo-Founder, Chairman of the Board & CEO
- Bradford K. AmmanPrincipal Accounting Officer
- Todd HuntsmanCo-Founder & Senior VP of Product and Technology
- RaeAnn ByrnesCo-Founder and Senior VP of Events & Clinical Advisory Services
- Susan McCulloughCo-Founder & Executive VP of Operations
- Roman Nehemiah FranklinChief Financial Officer
- Terry JonesSenior VP of Human Resources
- Nicholas M. DeGennaroSenior Vice President of Mergers and Acquisition Group
- Michael E. BruhnExecutive VP of Business Operations Integration
- Jennifer HauserExecutive Assistant to CEO and Chairman & CFO
Principais indicadores financeiros
Resultados divulgados pela Vivos Therapeutics Inc, em USD.
- Cap. de mercado
- 4,1 mi
- Receita (TTM)
- 20,9 mi
- P/L
- —
- LPA (diluído, TTM)
- -1.9
- Dividend yield
- —
- Margem de lucro
- -121.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 17,4 mi | -19,9 mi | -21,2 mi | |
| 15 mi | -11,2 mi | -11,1 mi | |
| 13,8 mi | -17,3 mi | -13,6 mi | |
| 16 mi | -25 mi | -23,8 mi |